Evaluation of fluorescence in situ hybridisation (FISH) for the identification of Candida albicans in comparison with three phenotypic methods

Mycoses

Volumn 55, Issue 3, 2012, Pages

  Lakner, Anna ^a   Essig, Andreas ^a   Frickmann, Hagen ^b,c   Poppert, Sven ^c  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

Blood culture; Candida; FISH; in situ hybridisation; Probe

Indexed keywords

AGAR; API32C AGAR; UNCLASSIFIED DRUG;

AGAR DIFFUSION; ANIMAL EXPERIMENT; ARTICLE; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CONTROLLED STUDY; DIAGNOSTIC TEST; FLUORESCENCE IN SITU HYBRIDIZATION; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS ISOLATION; GRAM STAINING; MOLECULAR PROBE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; YEAST;

CANDIDA ALBICANS; CANDIDIASIS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MYCOLOGICAL TYPING TECHNIQUES; PHYLOGENY; SENSITIVITY AND SPECIFICITY;

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS;

EID: 84859962588     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2011.02154.x     Document Type: Article

References (39)

1. Dimopoulos G, Ntziora F, Rachiotis G, Armaganidis A, Falagas ME. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg 2008; 106: 523-9. table of contents.
2. Lewis RE. Overview of the changing epidemiology of candidemia. Curr Med Res Opin 2009; 25: 1732-40.
3. Swinne D, Nolard N, Vanr P, Detandt M. Bloodstream yeast infections: a 15-month survey. Epidemiol Infec 2009; 137: 1037-40.
4. Patel GP, Simon D, Scheetz M, Crank CW, Lodise T, Patel N. The effect of time to antifungal therapy on mortality in Candidemia associated septic shock. Am J Ther 2009; 16: 508-11.
5. Hata DJ, Hall L, Fothergill AW, Larone DH, Wengenack NL. Multicenter evaluation of the new VITEK 2 advanced colorimetric yeast identification card. J Clin Microbiol 2007; 45: 1087-92.
6. Ells R, Kock JL, Pohl CH. Candida albicans or Candida dubliniensis? Mycoses 2009; 54: 1-16.
7. Eraso E, Moragues MD, Villar-Vidal M et al. Evaluation of the new chromogenic medium Candida ID 2 for isolation and identification of Candida albicans and other medically important Candida species. J Clin Microbiol 2006; 44: 3340-5.
8. Loreto ES, Scheid LA, Nogueira CW, Zeni G, Santurio JM, Alves SH. Candida dubliniensis: epidemiology and phenotypic methods for identification. Mycopathologia 2010; 169: 431-43.
9. Chowdhary A, Randhawa HS, Kowshik T, Kathuria S, Roy P, Brandt ME. Application of hypertonic Sabouraud glucose agar for differentiation of Candida dubliniensis from Candida albicans. Diagn Microbiol Infect Dis 2011; 69: 440-2.
10. Yan Y, He Y, Maier T et al. Improved identification of yeast species directly from positive blood culture media by combining Sepsityper specimen processing and Microflex analysis with the MALDI Biotyper system. J Clin Microbiol 2011; 7: 2528-32.
11. Putignani L, Del Chierico F, Onori M et al. MALDI-TOF mass spectrometry proteomic phenotyping of clinically relevant fungi. Mol Biosyst 2011; 7: 620-9.
12. Bader O, Weig M, Taverne-Ghadwal L, Lugert R, Gross U, Kuhns M. Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Microbiol Infect 2011; 9: 1359-65.
13. Sheth CC, Johnson E, Baker ME, Haynes K, Muhlschlegel FA. Phenotypic identification of Candida albicans by growth on chocolate agar. Med Mycol 2005; 43: 735-8.
14. Bautista-Munoz C, Boldo XM, Villa-Tanaca L, Hernandez-Rodriguez C. Identification of Candida spp. by randomly amplified polymorphic DNA analysis and differentiation between Candida albicans and Candida dubliniensis by direct PCR methods. J Clin Microbiol 2003; 41: 414-20.
15. Maaroufi Y, Heymans C, De Bruyne JM et al. Rapid detection of Candida albicans in clinical blood samples by using a TaqMan-based PCR assay. J Clin Microbiol 2003; 41: 3293-8.
16. Quiles-Melero I, Garcia-Rodriguez J, Romero-Gomez MP, Gomez-Sanchez P, Mingorance J. Rapid identification of yeasts from positive blood culture bottles by pyrosequencing. Eur J Clin Microbiol Infect Dis 2010; 30: 21-4.
17. Selvarangan R, Bui U, Limaye AP, Cookson BT. Rapid identification of commonly encountered Candida species directly from blood culture bottles. J Clin Microbiol 2003; 41: 5660-4.
18. Avni T, Leibovici L, Paul M. PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J Clin Microbiol 2010; 49: 665-70.
19. Pernthaler J, Gloeckner FO, Schoenhuber W, Amann R. Fluorescence in situ hybridization with rRNA-targeted oligonucleotide probes. In: Paul J (ed.), Methods in Microbiology: Marine Microbiology. London: Academic Press Ltd, 2001: 1-31.
20. Kempf VA, Trebesius K, Autenrieth IB. Fluorescent in situ hybridization allows rapid identification of microorganisms in blood cultures. J Clin Microbiol 2000; 38: 830-8.
21. Reller ME, Mallonee AB, Kwiatkowski NP, Merz WG. Use of peptide nucleic acid-fluorescence in situ hybridization for definitive, rapid identification of five common Candida species. J Clin Microbiol 2007; 45: 3802-3.
22. Rigby S, Procop GW, Haase G et al. Fluorescence in situ hybridization with peptide nucleic acid probes for rapid identification of Candida albicans directly from blood culture bottles. J Clin Microbiol 2002; 40: 2182-6.
23. Alexander BD, Ashley ED, Reller LB, Reed SD. Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures. Diagn Microbiol Infect Dis 2006; 54: 277-82.
24. Horvath A, Kristof K, Konkoly-Thege M, Nagy K. Rapid identification of pathogens in blood culture with fluorescent in situ hybridization (FISH). Acta Microbiol Immunol Hung 2010; 57: 225-34.
25. Moter A, Gobel UB. Fluorescence in situ hybridization (FISH) for direct visualization of microorganisms. J Microbiol Methods 2000; 41: 85-112.
26. Forrest GN, Mankes K, Jabra-Rizk MA et al. Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. J Clin Microbiol 2006; 44: 3381-3.
27. Bisha B, Kim HJ, Brehm-Stecher BF. Improved DNA-FISH for cytometric detection of Candida spp. J Appl Microbiol 2011; 4: 881-92.
28. Altschul SF, Madden TL, Schaffer AA et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997; 25: 3389-402.
29. Poppert S, Riecker M, Wellinghausen N, Frickmann H, Essig A. Accelerated identification of Staphylococcus aureus from blood cultures by a modified fluorescence in situ hybridization procedure. J Med Microbiol 2010; 59: 65-8.
30. Romeo O, Criseo G. Candida africana and its closest relatives. Mycoses 2011; 54: 475-86.
31. Podrazky O, Kuncova G, Krasowska A, Sigler K. Monitoring the growth and stress responses of yeast cells by two-dimensional fluorescence spectroscopy: first results. Folia Microbiol 2003; 48: 189-92.
32. Smail EH, Briza P, Panagos A, Berenfeld L. Candida albicans cell walls contain the fluorescent cross-linking amino acid dityrosine. Infect Immun 1995; 63: 4078-83.
33. Margo CE, Bombardier T. The diagnostic value of fungal autofluorescence. Surv Ophthalmol 1985; 29: 374-6.
34. Ilkit M, Hilmioglu S, Tasbakan M, Aydemir S. Evaluation of Albicans ID2 and Biggy agar for the isolation and direct identification of vaginal yeast isolates. J Med Microbiol 2007; 56: 762-5.
35. Sahand IH, Maza JL, Eraso E et al. Evaluation of CHROM-Pal medium for the isolation and direct identification of Candida dubliniensis in primary cultures from the oral cavity. J Med Microbiol 2009; 58: 1437-42.
36. Pasligh J, Radecke C, Fleischhacker M, Ruhnke M. Comparison of phenotypic methods for the identification of Candida dubliniensis. J Microbiol Immunol Infect 2010; 43: 147-54.
37. Buschelman B, Jones RN, Pfaller MA, Koontz FP, Doern GV. Colony morphology of Candida spp. as a guide to species identification. Diagn Microbiol Infect Dis 1999; 35: 89-91.
38. Yilmaz O, Demiray E. Clinical role and importance of fluorescence in situ hybridization method in diagnosis of H pylori infection and determination of clarithromycin resistance in H pylori eradication therapy. World J Gastroenterol 2007; 13: 671-5.
39. Martins ML, Ferreira AS, Sampaio A, Vieira R, Inacio J. Direct and specific identification of Cryptococcus neoformans in biological samples using fluorescently labelled DNA probes. Eur J Clin Microbiol Infect Dis 2010; 29: 571-6.